Convalescent Plasma for COVID-19 Patients (CPCP)

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

July 30, 2021

Conditions
COVID 19
Interventions
BIOLOGICAL

Convalescent Plasma as Therapy for Covid-19 patients

Patients in the treatment group will receive 500 ml from COVID-19 recovered donors

Trial Locations (1)

100000

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi

All Listed Sponsors
collaborator

National Institute of Hygiene and Epidemiology, Vietnam

OTHER

collaborator

National Hospital for Tropical Diseases, Hanoi, Vietnam

OTHER_GOV

collaborator

National Institute of Hematology and Blood Transfusion, Vietnam

OTHER

lead

Vinmec Research Institute of Stem Cell and Gene Technology

OTHER

NCT04521036 - Convalescent Plasma for COVID-19 Patients (CPCP) | Biotech Hunter | Biotech Hunter